DNA methylation and osteoarthritis

Epigenetics of Aging

Volumn , Issue , 2010, Pages 371-391

  Roach, Helmtrud I ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

cartilage degradation; cytokines; DNA methylation; epigenetics; matrix metalloprotease; osteoarthritis

Indexed keywords

EID: 84920025563     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0639-7_20     Document Type: Chapter

References (97)

1. Aigner, T., and Dudhia, J. 1997. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann. Rheum. Dis. 56:287-291.
2. Aigner, T., Fundel, K., Saas, J., Gebhard, P.M., Haag, J., Weiss, T., Zien, A., Obermayr, F., Zimmer, R., and Bartnik, E. 2006a. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum. 54:3533-3544.
3. Aigner, T., Saas, J., Zien, A., Zimmer, R., Gebhard, P. M., and Knorr, T. 2004. Analysis of differential gene expression in healthy and osteoarthritic cartilage and isolated chondrocytes by microarray analysis. Methods Mol. Med. 100:109-128.
4. Aigner, T., Sachse, A., Gebhard, P.M., and Roach, H. I. 2006b. Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention. Adv. Drug Deliv. Rev. 58:128-149.
5. Aigner, T., and Stove, J. 2003. Collagens - major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv. Drug Deliv. Rev. 55:1569-1593.
6. Aigner, T., Zien, A., Hanisch, D., and Zimmer, R. 2003. Gene expression in chondrocytes assessed with use of microarrays. J. Bone Joint Surg. Am. 85-A Suppl 2:117-123.
7. Aoyama, T., Okamoto, T., Nagayama, S., Nishijo, K., Ishibe, T., Yasura, K., Nakayama, T., Nakamura, T., and Toguchida, J. 2004. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. J. Biol. Chem. 279:28789-28797.
8. Attwood, J. T., Yung, R. L., and Richardson, B. C. 2002. DNA methylation and the regulation of gene transcription. Cell Mol. Life Sci. 59:241-257.
9. Ayache, N., Boumediene, K., Mathy-Hartert, M., Reginster, J. Y., Henrotin, Y., and Pujol, J. P. 2002. Expression of TGF-betas and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondrocytes. Osteoarthritis Cartilage. 10: 344-352.
10. Berger, S. L. 2007. The complex language of chromatin regulation during transcription. Nature. 447:407-412.
11. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6-21.
12. Brooks, W. H. 2005. Autoimmune disorders result from loss of epigenetic control following chromosome damage. Med. Hypotheses. 64:590-598.
13. Carrington, J. L. 2005. Aging bone and cartilage: cross-cutting issues. Biochem. Biophys. Res. Commun. 328:700-708.
14. Cheung, K. S., Hashimoto, K., Yamada, N., and Roach, H. I. 2008. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol. Int. [Epub ahead of print]:DOI 10.1007/s00296-008- 0744.
15. Chubinskaya, S., Kuettner, K. E., and Cole, A. A. 1999. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest. 79: 1669-1677.
16. da Silva, M. A., Yamada, N., Clarke, N. M., and Roach, H. I. 2008. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J. Orthop. Res. [E-pub ahead of print]:DOI 10.1002/jor.20799.
17. de Crombrugghe, B., Lefebvre, V., Behringer, R. R., Bi, W., Murakami, S., and Huang, W. 2000. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19:389-394.
18. de Crombrugghe, B., Lefebvre, V., and Nakashima, K. 2001. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 13:721-727.
19. Dessau, W., Sasse, J., Timpl, R., Jilek, F., and Von der, M. K. 1978. Synthesis and extracellular deposition of fibronectin in chondrocyte cultures. Response to the removal of extracellular cartilage matrix. J. Cell Biol. 79:342-355.
20. Dozin, B., Malpeli, M., Camardella, L., Cancedda, R., and Pietrangelo, A. 2002. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol. 21:449-459.
21. Duerr, S., Stremme, S., Soeder, S., Bau, B., and Aigner, T. 2004. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin. Exp. Rheumatol. 22:603-608.
22. Dumond, H., Presle, N., Terlain, B., Mainard, D., Loeuille, D., Netter, P., and Pottie, P. 2003. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum. 48:3118-3129.
23. Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V. K., Attwood, J., Burger, M., Burton, J., Cox, T. V., Davies, R., Down, T. A., Haefliger, C., Horton, R., Howe, K., Jackson, D. K., Kunde, J., Koenig, C., Liddle, J., Niblett, D., Otto, T., Pettett, R., Seemann, S., Thompson, C., West, T., Rogers, J., Olek, A., Berlin, K., and Beck, S. 2006. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38:1378-1385.
24. Enomoto, H., Inoki, I., Komiya, K., Shiomi, T., Ikeda, E., Obata, K., Matsumoto, H., Toyama, Y., and Okada, Y. 2003. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol. 162:171-181.
25. Esteller, M. 2007. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16 Spec No 1:R50-R59.
26. Fajardo, M., and Di Cesare, P. E. 2005. Disease-modifying therapies for osteoarthritis: current status. Drugs Aging. 22:141-161.
27. Fan, Z., Soder, S., Oehler, S., Fundel, K., and Aigner, T. 2007. Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am. J. Pathol. 171:938-946.
28. Feinberg, A. P. 2007. Phenotypic plasticity and the epigenetics of human disease. Nature. 447: 433-440.
29. Freemont, A. J., Hampson, V., Tilman, R., Goupille, P., Taiwo, Y., and Hoyland, J. A. 1997. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann. Rheum. Dis. 56:542-549.
30. Fujita, N., Watanabe, S., Ichimura, T., Tsuruzoe, S., Shinkai, Y., Tachibana, M., Chiba, T., and Nakao, M. 2003. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J. Biol. Chem. 278:24132-24138.
31. Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., and Kouzarides, T. 2003. The methyl- CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278:4035-4040.
32. Gan, Q., Yoshida, T., McDonald, O. G., and Owens, G. K. 2007. Epigenetic Mechanisms Contribute to Pluripotency and Cell Lineage Determination of Embryonic Stem Cells. Stem Cells. 25:2-9.
33. Goldring, M. B. 2006. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best. Pract. Res. Clin. Rheumatol. 20:1003-1025.
34. Goldring, M. B. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43: 1916-1926.
35. Goldring, M. B., and Goldring, S. R. 2007. Osteoarthritis. J. Cell Physiol. 213:626-634.
36. Goldring, S. R., and Goldring, M. B. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat Res. S27-S36.
37. Goldring, S. R., and Goldring, M. B. 2006. Clinical aspects, pathology and pathophysiology of osteoarthritis. J. Musculoskelet. Neuronal. Interact. 6:376-378.
38. Guenette, D. K., Ritzenthaler, J. D., Foley, J., Jackson, J. D., and Smith, B. D. 1992. DNA methylation inhibits transcription of procollagen alpha 2(I) promoters. Biochem. J. 283:699-703.
39. Hauselmann, H. J., Stefanovic-Racic, M., Michel, B. A., and Evans, C. H. 1998. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J. Immunol. 160:1444-1448.
40. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. 1991. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- And 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem. 266: 16485-16490.
41. Ijiri, K., Zerbini, L. F., Peng, H., Otu, H. H., Tsuchimochi, K., Otero, M., Dragomir, C., Walsh, N., Bierbaum, B. E., Mattingly, D., van, F. G., Komiya, S., Aigner, T., Libermann, T. A., and Goldring, M. B. 2008. Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum. 58: 2075-2087.
42. Iliopoulos, D., Malizos, K. N., and Tsezou, A. 2007. Epigenetic regulation of leptin affects MMP- 13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann. Rheum. Dis. 66:1616-1621.
43. Imai, K., Ohta, S., Matsumoto, T., Fujimoto, N., Sato, H., Seiki, M., and Okada, Y. 1997. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am. J. Pathol. 151:245-256.
44. Jaenisch, R., and Bird, A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 Suppl:245-254.
45. Kim, Y. I., Logan, J. W., Mason, J. B., and Roubenoff, R. 1996. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J. Lab Clin. Med. 128:165-172.
46. Leung, K. K., Ng, L. J., Ho, K. K., Tam, P. P., and Cheah, K. S. 1998. Different cis-regulatory DNA elements mediate developmental stage- And tissue-specific expression of the human COL2A1 gene in transgenic mice. J. Cell Biol. 141:1291-1300.
47. Li, D., Da, L., Tang, H., Li, T., and Zhao, M. 2008. CpG methylation plays a vital role in determining tissue- And cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding. Nucleic Acids Res. 36:330-341.
48. Lianxu, C., Hongti, J., and Changlong, Y. 2005. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14:367-376.
49. Loeser, R. F., Im, H. J., Richardson, B., Lu, Q., and Chubinskaya, S. 2008. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage [Epub ahead of publication] DOI:10.1016/j.joca.2008.08.003.
50. Lohmander, L. S., Englund, P. M., Dahl, L. L., and Roos, E. M. 2007. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am. J. Sports Med. 35: 1756-1769.
51. Loughlin, J. 2005. The genetic epidemiology of human primary osteoarthritis: current status. Expert. Rev. Mol. Med. 7:1-12.
52. Malfait, A. M., Liu, R. Q., Ijiri, K., Komiya, S., and Tortorella, M. D. 2002. Inhibition of ADAMTS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol. Chem. 277:22201-22208.
53. Mancini, D. N., Singh, S. M., Archer, T. K., and Rodenhiser, D. I. 1999. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene. 18:4108-4119.
54. Martin, C., and Zhang, Y. 2007. Mechanisms of epigenetic inheritance. Curr. Opin. Cell Biol. 19:266-272.
55. Masuhara, K., Bak, L. S., Nakai, T., Sugano, N., Ochi, T., and Sasaguri, Y. 2000. Matrix metalloproteinases in patients with osteoarthritis of the hip. Int. Orthop. 24:92-96.
56. Mehraban, F., Lark, M. W., Ahmed, F. N., Xu, F., and Moskowitz, R. W. 1998. Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis. Osteoarthritis Cartilage 6:286-294.
57. Milner, J. M., and Cawston, T. E. 2005. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr. Drug Targets. Inflamm. Allergy. 4:363-375.
58. Murphy, L., Schwartz, T. A., Helmick, C. G., Renner, J. B., Tudor, G., Koch, G., Dragomir, A., Kalsbeek, W. D., Luta, G., and Jordan, J. M. 2008. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59:1207-1213.
59. Neuhold, L. A., Killar, L., Zhao, W., Sung, M. L., Warner, L., Kulik, J., Turner, J., Wu, W., Billinghurst, C., Meijers, T., Poole, A. R., Babij, P., and DeGennaro, L. J. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107:35-44.
60. Nile, C. J., Read, R. C., Akil, M., Duff, G. W., and Wilson, A. G. 2008. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 58:2686-2693.
61. Ohta, S., Imai, K., Yamashita, K., Matsumoto, T., Azumano, I., and Okada, Y. 1998. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest. 78: 79-87.
62. Okada, Y., Shinmei, M., Tanaka, O., Naka, K., Kimura, A., Nakanishi, I., Bayliss, M. T., Iwata, K., and Nagase, H. 1992. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest. 66:680-690.
63. Pang, R. T., Lee, L. T., Ng, S. S., Yung, W. H., and Chow, B. K. 2004. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Mol. Endocrinol. 18:471-483.
64. Petronis, A. 2001. Human morbid genetics revisited: relevance of epigenetics. Trends Genet. 17:142-146.
65. Pogribny, I. P., Pogribna, M., Christman, J. K., and James, S. J. 2000. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis. Cancer Res. 60:588-594.
66. Pöschl, E., Fidler, A., Schmidt, B., Kallipolitou, A., Schmid, E., and Aigner, T. 2005. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann. Rheum. Dis. 64:477-480.
67. Pufe, T., Bartscher, M., Petersen, W., Tillmann, B., and Mentlein, R. 2003. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis. Cartilage. 11:260-264.
68. Reik, W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 447:425-432.
69. Roach, H. I. 2008. Potential directions for drug development for osteoarthritis. Expert. Opin. Drug Discovery. 3:475-487.
70. Roach, H. I., Aigner, T., Soder, S., Haag, J., and Welkerling, H. 2007. Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Curr. Drug Targets. 8:271-282.
71. Roach, H. I., and Clarke, N. M. P. 2000. Physiological cell death of chondrocytes in vivo is not confined to apoptosis: New observations on the mammalian growth plate. J. Bone Joint Surg. [Br]. 82-B:601-613.
72. Roach, H. I., and Hashimoto, K. 2007. PCR-based methods to determine DNA methylation status at specific CpG sites using methylation-sensitive restriction enzymes. In: Methods Express: PCR, ed. S. Hughes and A. Moody, pp. 279-292. Bloxham, Oxfordshire, UK: Scion Publishing Ltd.
73. Roach, H. I., Inglis, S., Partridge, K. A., Clarke, N. M. P., Oreffo, R. O. C., and Bronner, F. 2005a. Can changes in the DNA methylation pattern explain the clonally inherited altered phenotype of osteoarthritic chondrocytes? In: Proceedings of the 8th International Conference on the Chemistry and Biology of Mineralized Tissues, eds. W. Landis and J. Sodek, pp. 192-195. Toronto: University of Toronto.
74. Roach, H. I., and Tilley, S. 2007. The pathogenesis of osteoarthritis. In: Bone and Osteoarthritis, Volume 4, Topics in Bone Biology, eds. F. Bronner and M. C. Farach-Carson, pp. 1-18. London: Springer Verlag.
75. Roach, H. I., Yamada, N., Cheung, K. S., Tilley, S., Clarke, N. M., Oreffo, R. O., Kokubun, S., and Bronner, F. 2005b. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52:3110-3124.
76. Sanchez-Pernaute, O., Ospelt, C., Neidhart, M., and Gay, S. 2008. Epigenetic clues to rheumatoid arthritis. J. Autoimmun. 30:12-20.
77. Sandell, L. J., and Aigner, T. 2001. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 3:107-113.
78. Sandy, J. D., and Verscharen, C. 2001. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem. J. 358:615-626.
79. Sarzi-Puttini, P., Cimmino, M. A., Scarpa, R., Caporali, R., Parazzini, F., Zaninelli, A., Atzeni, F., and Canesi, B. 2005. Osteoarthritis: an overview of the disease and its treatment strategies. Semin. Arthritis Rheum. 35:1-10.
80. Sesselmann, S., Soder, S., Voigt, R., Haag, J., Grogan, S. P., and Aigner, T. 2008. DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis. Cartilage [Epub ahead of print] DOI:10.1016/j.joca.2008.09.006.
81. Shlopov, B. V., Gumanovskaya, M. L., and Hasty, K. A. 2000. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum. 43:195-205.
82. Soder, S., Roach, H. I., Oehler, S., Bau, B., Haag, J., and Aigner, T. 2006. MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin. Exp. Rheumatol. 24:302-304.
83. Spector, T. D., and Macgregor, A. J. 2004. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage. 12 Suppl A:S39-S44.
84. Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., Fourie, A. M., and Fosang, A. J. 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 434:648-652.
85. Stirzaker, C., Song, J. Z., Davidson, B., and Clark, S. J. 2004. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64:3871-3877.
86. Strunnikova, M., Schagdarsurengin, U., Kehlen, A., Garbe, J. C., Stampfer, M. R., and Dammann, R. 2005. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol. Cell Biol. 25:3923-3933.
87. Tetlow, L. C., Adlam, D. J., and Woolley, D. E. 2001. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 44:585-594.
88. Tortorella, M. D., Malfait, A. M., Deccico, C., and Arner, E. 2001. The role of ADAMTS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage. 9:539-552.
89. Tsuchiya, K., Maloney, W. J., Vu, T., Hoffman, A. R., Schurman, D. J., and Smith, R. L. 1996. RT-PCR analysis of MMP-9 expression in human articular cartilage chondrocytes and synovial fluid cells. Biotech. Histochem. 71:208-213.
90. Valdes, A. M., Doherty, M., and Spector, T. D. 2008. The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann. Rheum. Dis. 67:124-127.
91. Wagner, S., Hofstetter, W., Chiquet, M., Mainil-Varlet, P., Stauffer, E., Ganz, R., and Siebenrock, K. A. 2003. Early osteoarthritic changes of human femoral head cartilage subsequent to femoro-acetabular impingement. Osteoarthritis Cartilage. 11:508-518.
92. Walter, H., Kawashima, A., Nebelung, W., Neumann, W., and Roessner, A. 1998. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol. Res. Pract. 194:73-81.
93. Wolfe, G. C., MacNaul, K. L., Buechel, F. F., McDonnell, J., Hoerrner, L. A., Lark, M.W., Moore, V. L., and Hutchinson, N. I. 1993. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum. 36:1540-1547.
94. Wu, C. W., and Kalunian, K. C. 2005. New developments in osteoarthritis. Clin. Geriatr. Med. 21:589-601.
95. Wu, W., Billinghurst, R. C., Pidoux, I., Antoniou, J., Zukor, D., Tanzer, M., and Poole, A. R. 2002. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum. 46:2087-2094.
96. Yamane, K., Suzuki, H., Ihn, H., Kato, M., Yoshikawa, H., and Tamaki, K. 2005. Cell type-specific regulation of the TGF-beta-responsive alpha2(I) collagen gene by CpG methylation. J. Cell Physiol. 202:822-830.
97. Zimmermann, P., Boeuf, S., Dickhut, A., Boehmer, S., Olek, S., and Richter, W. 2008. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 58:2743-2753.